Comment to: "Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome-Associated Paroxysmal Movement Disorders"
Mov Disord
.
2024 Oct;39(10):1898-1899.
doi: 10.1002/mds.29983.
Authors
Emmanuel Roze
1
2
,
Aurélie Méneret
1
2
,
Elodie Hainque
1
2
,
Fanny Mochel
1
3
Affiliations
1
Sorbonne Université, Institut du Cerveau, Inserm, CNRS, AP-HP, Paris, France.
2
Department of Neurology, AP-HP, Hôpital Pitié-Salpêtrière, DMU Neurosciences, Paris, France.
3
Department of Genetics, AP-HP, Hôpital Pitié-Salpêtrière, DMU BioGeM, Paris, France.
PMID:
39425519
DOI:
10.1002/mds.29983
No abstract available
Publication types
Letter